Cefixime Dispersible Tablets

Beta Lactams · Dispersible Tablets · 100mg / 200mg / 400mg

Trade Information

Minimum Order Qty	10,000 tablets
Capacity	100 Million Tablets per month
Strength	100mg / 200mg / 400mg
Private Labelling	Custom branding, artwork & market-specific labelling
Lead Time	45–60 days from order confirmation
Payment Terms	LC at sight, TT (advance / against documents)
Shipping	FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia	BP, USP, IP compliant

Packing Options

Blister (Alu-Alu / Alu-PVC)
Strip pack
Hospital bulk pack
Custom packing as per buyer requirement

Regulatory & Quality

Registration Status	Registered in multiple African, Asian, and CIS markets. Dossier available for new market registration.
Regulatory Dossiers	CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data	Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification	WHO-GMP Certified

Product Details

Composition	Cefixime Trihydrate
Dosage Form	Dispersible Tablets
Pack Size	1x10, 10x10 / Custom packing available
Storage	Store below 30°C in a dry place, protected from light and moisture
Shelf Life	24 months from date of manufacture

Description

Cefixime is a third-generation oral cephalosporin antibiotic with broad-spectrum activity against gram-negative and some gram-positive bacteria. It is listed on the WHO Model List of Essential Medicines and is one of the most widely prescribed oral cephalosporins globally.

The dispersible tablet formulation is particularly important for paediatric use, allowing the tablet to be dissolved in water for easy administration to children. It is also suitable for adult patients who have difficulty swallowing conventional tablets.

BioGalen manufactures Cefixime Dispersible Tablets in 100mg, 200mg, and 400mg strengths. Our products are widely exported to Africa, Southeast Asia, and CIS countries for both hospital and retail pharmacy distribution. Cefixime is a high-demand antibiotic in primary healthcare settings across these regions.

Mechanism of Action

Cefixime is a third-generation cephalosporin that exerts its bactericidal action by binding to penicillin-binding proteins (PBPs) in bacterial cell walls, specifically PBP-3. This inhibits the final transpeptidation step of peptidoglycan synthesis, weakening the cell wall structure and leading to osmotic lysis and cell death. As a third-generation cephalosporin, Cefixime has enhanced stability against beta-lactamase enzymes produced by many gram-negative bacteria, giving it broader coverage than first and second-generation cephalosporins. It is particularly effective against common respiratory and urinary pathogens including Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and many Enterobacteriaceae. Its oral bioavailability of 40–50% provides adequate tissue concentrations for outpatient treatment of moderate infections.

Indications

Upper and lower respiratory tract infections
Urinary tract infections (uncomplicated and complicated)
Otitis media (middle ear infection)
Pharyngitis and tonsillitis
Acute bronchitis
Gonorrhoea (uncomplicated, single-dose)
Typhoid fever

Available Variants

Cefixime Dispersible Tablet 100mg
Cefixime Dispersible Tablet 200mg
Cefixime Dispersible Tablet 400mg
Cefixime Dry Syrup 50mg

Frequently Asked Questions

Why are dispersible tablets preferred over conventional tablets for Cefixime?

Dispersible tablets dissolve in a small amount of water to form a uniform suspension, enabling accurate weight-based dosing for paediatric patients. They are also preferred in markets with high paediatric disease burden (malaria, pneumonia, typhoid) where oral antibiotics must be administered to young children. For B2B buyers, dispersible formulations are increasingly specified in WHO treatment guidelines and government tender requirements.

How does Cefixime compare to Amoxicillin for market positioning?

Amoxicillin is a first-line, high-volume antibiotic for primary healthcare. Cefixime is a second-line, higher-value product used when first-line antibiotics fail or when beta-lactamase-producing organisms are suspected. Most distributors carry both — Amoxicillin for volume and Cefixime for value. Together they cover the majority of outpatient antibiotic prescribing.

What strengths are available and which are most in demand?

BioGalen manufactures Cefixime DT in 100mg (paediatric), 200mg (standard adult), and 400mg (high-dose adult) strengths plus a 50mg dry syrup. The 200mg DT is the highest-volume SKU across most African and Asian markets. The 100mg DT and dry syrup are essential for paediatric-focused procurement.

Is Cefixime manufactured in a dedicated beta-lactam facility?

Yes. BioGalen manufactures all beta-lactam products including Cefixime in a dedicated, segregated beta-lactam manufacturing block as required by WHO-GMP and regulatory authorities. This eliminates cross-contamination risk and is a key requirement for regulatory approvals and tender eligibility.

Interested in Cefixime Dispersible Tablets?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.

WhatsApp Enquiry Contact Us

Browse Categories

Browse by Dosage Form